Search Results

There are 39435 results for: content related to: Calcium-antagonist effects of norbormide on isolated perfused heart and cardiac myocytes of guinea-pig: a comparison with verapamil

  1. You have free access to this content
    Ca2+ entry blocking and contractility promoting actions of norbormide in single rat caudal artery myocytes

    British Journal of Pharmacology

    Volume 137, Issue 3, October 2002, Pages: 323–328, Fabio Fusi, Simona Saponara, Giampietro Sgaragli, Gabriella Cargnelli and Sergio Bova

    Version of Record online : 2 FEB 2009, DOI: 10.1038/sj.bjp.0704877

  2. Comprehensive cytotoxic evaluation of morin, a bioflavonoid against verapamil on rat gastrointestinal epithelium for novel pharmaceutical application involving P-glycoprotein inhibition

    Journal of Pharmacy and Pharmacology

    Volume 67, Issue 8, August 2015, Pages: 1083–1099, Gurunath Surampalli, Basavaraj K. Nanjwade and Paragouda A. Patil

    Version of Record online : 13 APR 2015, DOI: 10.1111/jphp.12400

  3. Verapamil Hydrochloride: Pharmacological Properties and Role in Cardiovascular Therapeutics

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 2, Issue 6, November-December 1982, Pages: 328–350, Ms. Sherrin H. Baky and Dr. Bramah N. Singh

    Version of Record online : 24 JAN 2012, DOI: 10.1002/j.1875-9114.1982.tb03210.x

  4. You have full text access to this OnlineOpen article
    The putative P-gp inhibitor telmisartan does not affect the transcellular permeability and cellular uptake of the calcium channel antagonist verapamil in the P-glycoprotein expressing cell line MDCK II MDR1

    Pharmacology Research & Perspectives

    Volume 3, Issue 4, August 2015, Lasse Saaby, Peer Tfelt-Hansen and Birger Brodin

    Version of Record online : 11 JUN 2015, DOI: 10.1002/prp2.151

  5. You have free access to this content
    Effect of K+ and Rb+ on the action of verapamil on a voltage-gated K+ channel, hKv1.3: implications for a second open state?

    British Journal of Pharmacology

    Volume 157, Issue 5, July 2009, Pages: 757–768, Z Kuras and S Grissmer

    Version of Record online : 9 APR 2009, DOI: 10.1111/j.1476-5381.2009.00202.x

  6. Faster clearance of sustained release verapamil in men versus women: Continuing observations on sex-specific differences after oral administration of verapamil

    Clinical Pharmacology & Therapeutics

    Volume 68, Issue 3, September 2000, Pages: 286–292, Mary Ellen Krecic-Shepard, Crissy R. Barnas, Jill Slimko and Janice B. Schwartz

    Version of Record online : 2 SEP 2000, DOI: 10.1067/mcp.2000.109356

  7. Verapamil stereoisomers during racemic verapamil administration: Effects of aging and comparisons to administration of individual stereoisomers

    Clinical Pharmacology & Therapeutics

    Volume 56, Issue 4, October 1994, Pages: 368–376, Janice B Schwartz, Helen Capili and Irving W Wainer

    Version of Record online : 15 OCT 1994, DOI: 10.1038/clpt.1994.151

  8. Calcium channel antagonists for the treatment of bipolar disorder

    Bipolar Disorders

    Volume 2, Issue 2, June 2000, Pages: 108–119, Naomi A Levy and Philip G Janicak

    Version of Record online : 24 DEC 2001, DOI: 10.1034/j.1399-5618.2000.020204.x

  9. In vivo comparison of putative probes of CYP3A4/5 activity: erythromycin, dextromethorphan, and verapamil

    Clinical Pharmacology & Therapeutics

    Volume 66, Issue 1, July 1999, Pages: 40–50, Mary Ellen Krecic-Shepard, Crissy R. Barnas, Jill Slimko, J. Christopher Gorski, Irving W. Wainer and Janice B. Schwartz

    Version of Record online : 22 JUL 1999, DOI: 10.1016/S0009-9236(99)70052-4

  10. Effect of Verapamil on the Pharmacokinetics of Aliskiren in Healthy Participants

    The Journal of Clinical Pharmacology

    Volume 51, Issue 2, February 2011, Pages: 218–228, Sam Rebello, Selene Leon, Sam Hariry, Marion Dahlke and Venkateswar Jarugula

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010365717

  11. You have free access to this content
    Non-linear pharmacokinetics of high-dose intravenous verapamil

    British Journal of Clinical Pharmacology

    Volume 44, Issue 3, September 1997, Pages: 255–260, G. Toffoli, I. Robieux, D. Fantin, M. Gigante, S. Frustaci, G. L. Nicolosi, M. De Cicco and M. Boiocchi

    Version of Record online : 2 OCT 2003, DOI: 10.1046/j.1365-2125.1997.t01-1-00574.x

  12. Disposition and pharmacologic effects of R/S-verapamil in patients with chronic atrial fibrillation: An investigation comparing single and multiple dosing

    Clinical Pharmacology & Therapeutics

    Volume 69, Issue 5, May 2001, Pages: 324–332, Dagmar Busse, Martin F. Fromm, Klaus Mörike, Siegfried Drescher, Volker Kühlkamp and Michel Eichelbaum

    Version of Record online : 2 MAY 2001, DOI: 10.1067/mcp.2001.115125

  13. You have free access to this content
    Application of permeability-limited physiologically-based pharmacokinetic models: Part II - prediction of p-glycoprotein mediated drug–drug interactions with digoxin

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 9, September 2013, Pages: 3161–3173, Sibylle Neuhoff, Karen Rowland Yeo, Zoe Barter, Masoud Jamei, David B. Turner and Amin Rostami-Hodjegan

    Version of Record online : 19 MAY 2013, DOI: 10.1002/jps.23607

  14. A Reduced Third Order Markov Model for Ethylene-Norbornene Copolymerization Kinetics with Homogeneous Metallocene Catalysts

    Macromolecular Reaction Engineering

    Volume 1, Issue 1, January 9, 2007, Pages: 68–77, Seung Young Park, Jongku Lee and Kyu Yong Choi

    Version of Record online : 22 JAN 2007, DOI: 10.1002/mren.200600002

  15. Pharmacokinetics of P-glycoprotein inhibition in the rat blood-brain barrier

    Journal of Pharmaceutical Sciences

    Volume 97, Issue 12, December 2008, Pages: 5386–5400, Stina Syvänen, Andrew Hooker, Obaidur Rahman, Helena Wilking, Gunnar Blomquist, Bengt Långström, Mats Bergström and Margareta Hammarlund-Udenaes

    Version of Record online : 2 APR 2008, DOI: 10.1002/jps.21359

  16. Extracellular calcium protects against verapamil-induced metaphase-II arrest and initiation of apoptosis in aged rat eggs

    Cell Biology International

    Volume 33, Issue 3, March 2009, Pages: 337–343, S.K. Chaube, Anima Tripathi, Sabana Khatun, S.K. Mishra, P.V. Prasad and T.G. Shrivastav

    Version of Record online : 2 JAN 2013, DOI: 10.1016/j.cellbi.2009.01.001

  17. You have free access to this content
    Oral bioavailability of dabigatran etexilate (Pradaxa®) after co-medication with verapamil in healthy subjects

    British Journal of Clinical Pharmacology

    Volume 75, Issue 4, April 2013, Pages: 1053–1062, Sebastian Härtter, Regina Sennewald, Gerhard Nehmiz and Paul Reilly

    Version of Record online : 15 MAR 2013, DOI: 10.1111/j.1365-2125.2012.04453.x

  18. You have free access to this content
    The multidrug-resistance-reverser verapamil interferes with cellular P-glycoprotein-mediated pumping of daunorubicin as a non-competing substrate

    European Journal of Biochemistry

    Volume 221, Issue 1, April 1994, Pages: 363–373, Ellen C. SPOELSTRA, Hans V. WESTERHOFF, Herbert M. PINEDO, Henk DEKKER and Jan LANKELMA

    Version of Record online : 3 MAR 2005, DOI: 10.1111/j.1432-1033.1994.tb18748.x

  19. Determination of in vivo absorption, metabolism, and transport of drugs by the human intestinal wall and liver with a novel perfusion technique

    Clinical Pharmacology & Therapeutics

    Volume 70, Issue 3, September 2001, Pages: 217–227, Oliver von Richter, Bernd Greiner, Martin F. Fromm, Robert Fraser, Taher Omari, Murray L. Barclay, John Dent, Andrew A. Somogyi and Michel Eichelbaum

    Version of Record online : 27 SEP 2001, DOI: 10.1067/mcp.2001.117937

  20. You have free access to this content
    Antiarrhythmic actions of verapamil against ischaemic arrhythmias in the rat

    British Journal of Pharmacology

    Volume 83, Issue 2, October 1984, Pages: 373–385, M.J. Curtis, B.A. MacLeod and M.J.A. Walker

    Version of Record online : 19 JUL 2012, DOI: 10.1111/j.1476-5381.1984.tb16497.x